1. Home
  2. STNE vs CORT Comparison

STNE vs CORT Comparison

Compare STNE & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo StoneCo Ltd.

STNE

StoneCo Ltd.

HOLD

Current Price

$17.08

Market Cap

4.4B

Sector

Technology

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$40.83

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STNE
CORT
Founded
2012
1998
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.7B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
STNE
CORT
Price
$17.08
$40.83
Analyst Decision
Buy
Buy
Analyst Count
7
6
Target Price
$16.86
$114.20
AVG Volume (30 Days)
5.3M
2.1M
Earning Date
03-02-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.87
Revenue
$2,670,485,228.00
$741,172,000.00
Revenue This Year
$15.38
$23.09
Revenue Next Year
$6.49
$29.62
P/E Ratio
N/A
$46.75
Revenue Growth
24.14
17.92
52 Week Low
$8.64
$32.99
52 Week High
$19.95
$117.33

Technical Indicators

Market Signals
Indicator
STNE
CORT
Relative Strength Index (RSI) 54.43 36.13
Support Level $15.85 $38.10
Resistance Level $16.87 $41.36
Average True Range (ATR) 0.74 2.35
MACD 0.05 1.19
Stochastic Oscillator 61.45 39.46

Price Performance

Historical Comparison
STNE
CORT

About STNE StoneCo Ltd.

StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services segment, which includes payments solutions, digital banking, credit, insurance solutions as well as the registry business. In the Software segment solution includes POS/ERP, TEF and QR Code gateways, reconciliation, CRM, OMS, e-commerce platform, engagement tool, ads solution, and marketplace hub. It generates the majority of its revenue from the Financial Services segment.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: